UNSPSC 51182009: Methyltestosterone

This classification denotes a therapeutic androgen with the molecular formula C20H30O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V9EFU16ZIF, chemically known as testosterone, 17-methyl- but generally known as 17-methyltestosterone, which bears US NIH Compound Identifier 6010. European Medicines Agency schedules Methyltestosterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08876MIG.

UNSPSC 51182009 Methyltestosterone is a Commodity code capturing prescription pharmaceutical active ingredients and formulations that state and local government health systems, correctional facilities, and institutional healthcare providers procure through cooperative purchasing agreements and direct supply contracts. The recent activity under this code reflects broad-based pharmaceutical procurement by state and local entities rather than methyltestosterone-specific demand; state and local governments buy methyltestosterone as part of larger generic multi-source pharmaceutical bundles sourced through authorized wholesalers and subject to cGMP and Drug Supply Chain Security Act compliance. Issuing bodies include state pharmacy cooperatives, departments of administration overseeing institutional healthcare purchasing, and participating state and local health facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is a repeat vehicle for this category of pharmaceutical procurement across member states.

MMCAP's January 2026 RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802) spans Minnesota and Oregon and closes March 26, 2026, requiring vendors to supply comprehensive product portfolios through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with pricing weighted on competitiveness (75 percent), fixed contract pricing (10 percent), EDI capability (5 percent), administrative fee compliance (5 percent), and data format compliance (5 percent). Vendors must demonstrate contractual relationships with at least two of the three wholesalers, maintain $5 million commercial general liability insurance and $2 million network security and privacy liability, and comply with a 3 percent administrative fee on all purchases. The contract term runs two years for new responders with optional extensions; incumbent responders align with existing expiration dates through June 30, 2028. Products must be available in the marketplace by May 15, 2026, with resulting agreements effective July 1, 2026.